Healthcare Services

Decentralized Clinical Trials Market Growth Expected to Reach $19.55 Billion by 2030 with 17.3% CAGR

March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Size Growth Is Projected For The Decentralized Clinical Trials Market During The Forecast Period 2026–2030?

The decentralized clinical trials market has seen rapid expansion in recent years. It is projected to increase from $8.77 billion in 2025 to $10.31 billion in 2026, at a compound annual growth rate (CAGR) of 17.7%. Historically, this growth can be ascribed to factors such as the increasing complexity of clinical trials, a heightened need for patient recruitment efficiency, the proliferation of digital health technologies, the expanding use of electronic data capture systems, and a growing regulatory acceptance of decentralized models.

The market size for decentralized clinical trials is anticipated to experience substantial expansion over the upcoming years. This market is projected to reach $19.55 billion by 2030, expanding at a compound annual growth rate (CAGR) of 17.3%. The expansion during the forecast period is primarily driven by the increasing integration of hybrid trial designs, a growing need for quicker drug development timelines, the broadening scope of global virtual trials, the rising application of AI-driven trial optimization, and an intensified focus on diverse patient involvement. Significant trends expected in this period involve the wider uptake of remote patient monitoring tools, the increased utilization of virtual trial platforms, the expansion of data collection through wearables, the growing implementation of real-time trial analytics, and an elevated emphasis on patient-centric trial design.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28189&type=smp

What Underlying Factors Are Accelerating The Growth Of The Decentralized Clinical Trials Market?

An increasing emphasis on telemedicine is anticipated to drive expansion within the decentralized clinical trials market in the future. Telemedicine involves providing health services remotely through digital communication technologies, enabling medical consultations and patient monitoring without requiring physical presence at healthcare facilities. This growing focus on telemedicine largely stems from the demand for accessible healthcare delivery, particularly in response to global health challenges and social distancing requirements. Decentralized clinical trials leverage telemedicine to remotely engage and oversee patients, thereby minimizing in-person visits while simultaneously enabling real-time data collection, enhanced access, and continuous supervision. For instance, in September 2024, according to the Australian Bureau of Statistics (ABS), the national statistical agency of Australia, in 2023–24, 83.5% of males reported using telehealth services, an increase from 78.6% in 2022–23. Consequently, the rising focus on telemedicine is propelling the growth of the decentralized clinical trials market.

What Market Segments Are Evaluated Within The Decentralized Clinical Trials Market?

The decentralized clinical trials market covered in this report is segmented –

1) By Type: Interventional, Observational, Expanded Access

2) By Technology Used: Wearable Devices, Mobile Health Applications, Telemedicine Platforms, Electronic Data Capture Systems

3) By Study Phase: Phase I, Phase II, Phase III, Phase IV

4) By Therapeutic Area: Oncology, Cardiology, Neurology, Infectious Diseases

5) By End-User: Pharmaceutical Companies, Biotechnology Firms, Contract Research Organizations, Regulatory Authorities, Academic And Research Institutions

Subsegments:

1) By Interventional: Randomized Controlled Trials (RCTs), Non-Randomized Trials, Adaptive Clinical Trials, Pragmatic Clinical Trials

2) By Observational: Cohort Studies, Case-Control Studies, Cross-Sectional Studies, Prospective Studies, Retrospective Studies, Longitudinal Studies

3) By Expanded Access: Treatment Investigational New Drug (IND) Applications, Intermediate-Size Patient Population Investigational New Drug (IND) Applications, Single-Patient Investigational New Drug (IND) Applications, Emergency Use Investigational New Drug (IND) Applications

What Key Developments And Trends Are Impacting The Decentralized Clinical Trials Market?

Leading companies within the decentralized clinical trials market are concentrating on creating sophisticated tools, such as integrated, no-code clinical trials software. This aims to streamline trial setup and administration, boosting overall efficiency and patient involvement. Such all-in-one, no-code software enables researchers to conceptualize, manage, and execute trials without requiring programming knowledge, while seamlessly consolidating patient acquisition, data collection, oversight, and analysis onto a singular, easy-to-use platform. For example, in August 2024, Medable, a clinical technology company based in the US, introduced Medable Studio. This is an all-in-one, no-code software solution engineered to simplify and speed up the configuration, translation, validation, and deployment of electronic Clinical Outcome Assessments (eCOA), eConsent, Televisit, and sensors Plus within clinical trials. It allows biopharmaceutical firms to craft protocol-specific study designs in hours rather than months, affording users increased command, clarity, and pace. Furthermore, it provides adaptable self-service, full-service, or combined approaches, significantly cutting down study initiation periods and expenditures. The platform’s objective is to transform trial execution by making the study construction process quicker, more effective, and less reliant on specialized external assistance.

Who Are The Top Market Participants Influencing The Decentralized Clinical Trials Market?

Major companies operating in the decentralized clinical trials market are Walgreens Boots Alliance Inc., Pfizer Inc., Oracle Corporation, Thermo Fisher Scientific Inc., IQVIA Holdings Inc., Labcorp Holdings Inc., ICON Public Limited Company, Dassault Systèmes SE, LEO Pharma A/S, Verily Life Sciences LLC, ProPharma, Signant Health Holding Corp., PCM Trials, Huma Therapeutics Limited, Medable Inc., Science 37 Inc., Obvio Health, EmVenio Research Inc., Grove AI Inc., Phesi Inc.

Read the full decentralized clinical trials market report here:

https://www.thebusinessresearchcompany.com/report/decentralized-clinical-trials-global-market-report

Which Region Is Projected To Dominate The Decentralized Clinical Trials Market During The Forecast Period?

North America was the largest region in the decentralized clinical trials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the decentralized clinical trials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Decentralized Clinical Trials Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28189&type=smp

Browse Through More Reports Similar to the Global Decentralized Clinical Trials Market 2026, By The Business Research Company

Healthcare Data Integration Global Market Report

https://www.thebusinessresearchcompany.com/report/healthcare-data-integration-global-market-report

Personal Health Record Software Global Market Report

https://www.thebusinessresearchcompany.com/report/personal-health-record-software-global-market-report

Genomics Personalized Health Global Market Report

https://www.thebusinessresearchcompany.com/report/genomics-personalized-health-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795